The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation.
about
Immune Checkpoint Modulators: An Emerging Antiglioma ArmamentariumThe impact of the myeloid response to radiation therapyRadiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sproutingRadiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathway.Retinal whole genome microarray analysis and early morphological changes in the optic nerves of monkeys after an intraorbital nerve irradiated injury.The association of apoptotic protein expressions sensitive to apoptosis gene, p73 and p53 with the prognosis of cervical carcinoma.The role of p53 in determining sensitivity to radiotherapy.The effect of elemene on lung adenocarcinoma A549 cell radiosensitivity and elucidation of its mechanism.Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete RemissionsMalignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromesRadiation-induced effects and the immune system in cancer.Two cases with fatal outcome following total lung irradiation for metastatic bone sarcoma.An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation.DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells.Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapyTargeting prostate cancer based on signal transduction and cell cycle pathways.The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaPA hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma.Accurate accumulation of dose for improved understanding of radiation effects in normal tissue.Combination approaches to immunotherapy: the radiotherapy example.MAGNETIC NANOPARTICLE HYPERTHERMIA IN CANCER TREATMENT.The future of glioblastoma therapy: synergism of standard of care and immunotherapy.Biological determinants of radioresistance and their remediation in pancreatic cancer.Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice.Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters.New specific molecular targets for radio-chemotherapy of rectal cancer.Genistein induces radioprotection by hematopoietic stem cell quiescence.Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancer.
P2860
Q26765459-F96C6085-BEA9-4631-A251-ADFFE3653D8EQ26851643-45A3A43C-48DA-4FA2-9DA7-83350A29E085Q33605773-DB6A6223-0494-497D-BB77-D71C4DE5D91BQ33926909-194B2807-738A-4261-B6E8-D13B7AE6D0F2Q34086496-95EEA083-306C-41F0-A88E-0F06BA494D0AQ34610533-F4542CE7-E95E-45E5-A838-67D9236AEFFEQ35058584-C4918B7A-00F9-46C8-9D3F-0FB6599E2E0FQ35899658-82521975-9A19-40FB-BE1D-23AC65528408Q35958252-E5C9C535-2625-4FF6-9C62-92BD6231F9DAQ36254710-FC2EC7E0-67E7-4196-B408-2D087D3B094CQ36469945-2218D5B0-3846-4DEE-9790-935BA917BF6BQ36491549-6FB74D34-8272-4421-B681-51CF0094E821Q36644150-C112A218-BB16-4A6C-BDDA-50D3F36D11B6Q36734546-A83F9A7F-8FFD-478C-9AB4-ED8792757806Q36842135-3F2C25DC-35D9-4FD6-8F82-FA122663D573Q36995054-09DEB9DE-F085-4C04-86A4-4DF342601E4FQ37084449-301283F8-AF46-44E6-B519-85F2AC6D0EADQ37178662-6E28775B-62BD-4D39-9370-0CA96E379C0DQ37695541-A4BCDBC4-8E84-41C3-B0CB-24BCEF63D534Q37773250-61EC5CCE-C82C-4168-8561-06109A8079CEQ38172159-BF2CDFD3-91F6-49F8-8707-DF99930A51F9Q38255481-D6D1CD05-5AEB-458B-A719-F734D5762527Q39156722-F12168C7-380F-400A-AB14-2A18BD2F6544Q39655881-45EC60E0-DC93-4145-A9A6-3544733E3C98Q40223437-4529445E-F03F-4F7B-BCE9-5A167ED94FC7Q41130691-C0C9B1BB-5F85-4042-A010-BFC832CE830AQ46343587-0650F4E7-3247-41E0-AC8C-0208A42712E5Q53173327-73AC0EF6-DF1F-4A3A-A8AD-7EBD583680B3
P2860
The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The molecular and cellular bas ...... pond to therapeutic radiation.
@ast
The molecular and cellular bas ...... pond to therapeutic radiation.
@en
The molecular and cellular bas ...... pond to therapeutic radiation.
@nl
type
label
The molecular and cellular bas ...... pond to therapeutic radiation.
@ast
The molecular and cellular bas ...... pond to therapeutic radiation.
@en
The molecular and cellular bas ...... pond to therapeutic radiation.
@nl
prefLabel
The molecular and cellular bas ...... pond to therapeutic radiation.
@ast
The molecular and cellular bas ...... pond to therapeutic radiation.
@en
The molecular and cellular bas ...... pond to therapeutic radiation.
@nl
P2093
P1433
P1476
The molecular and cellular bas ...... pond to therapeutic radiation.
@en
P2093
P356
10.1080/07357909909011718
P577
1999-01-01T00:00:00Z